- Home
- CORT vs ENSG Comparison
CORT vs ENSG Comparison
Compare CORT & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- ENSG
- Stock Information
- Founded
- CORT 1998
- ENSG 1999
- Country
- CORT United States
- ENSG United States
- Employees
- CORT N/A
- ENSG N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- ENSG Hospital/Nursing Management
- Sector
- CORT Health Care
- ENSG Health Care
- Exchange
- CORT Nasdaq
- ENSG Nasdaq
- Market Cap
- CORT 7.6B
- ENSG 8.9B
- IPO Year
- CORT N/A
- ENSG 2007
- Fundamental
- Price
- CORT $71.66
- ENSG $166.15
- Analyst Decision
- CORT Strong Buy
- ENSG Buy
- Analyst Count
- CORT 4
- ENSG 7
- Target Price
- CORT $139.00
- ENSG $171.86
- AVG Volume (30 Days)
- CORT 640.1K
- ENSG 338.2K
- Earning Date
- CORT 10-29-2025
- ENSG 10-23-2025
- Dividend Yield
- CORT N/A
- ENSG 0.15%
- EPS Growth
- CORT N/A
- ENSG 41.66
- EPS
- CORT 1.11
- ENSG 5.52
- Revenue
- CORT $716,080,000.00
- ENSG $4,614,838,000.00
- Revenue This Year
- CORT $30.62
- ENSG $19.59
- Revenue Next Year
- CORT $37.68
- ENSG $10.78
- P/E Ratio
- CORT $64.27
- ENSG $30.11
- Revenue Growth
- CORT 25.71
- ENSG 16.31
- 52 Week Low
- CORT $34.34
- ENSG $118.73
- 52 Week High
- CORT $117.33
- ENSG $174.98
- Technical
- Relative Strength Index (RSI)
- CORT 53.12
- ENSG 49.74
- Support Level
- CORT $67.32
- ENSG $165.05
- Resistance Level
- CORT $72.52
- ENSG $174.70
- Average True Range (ATR)
- CORT 1.92
- ENSG 3.24
- MACD
- CORT 0.14
- ENSG -1.09
- Stochastic Oscillator
- CORT 64.27
- ENSG 11.08
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.